Viking Therapeutics stock crumbled despite seemingly positive test results for a drug that treats a serious liver disease. Back to Top ...

Viking Therapeutics stock crumbled Tuesday despite seemingly positive test results for a drug that treats a serious liver disease.Please watch the video at Investors.com - Glitches, Elections And ...

So today is also about that, making up for experiences lost. We look back on that, very, very fortunate that Justin became a ...

Viking Therapeutics (VKTX) stock fell after a conference call discussing data from a successful mid-stage trial for its liver ...

Vikings receiver Justin Jefferson returned to team headquarters for the first day of a mandatory minicamp on Tuesday to ...

Jefferson will also receive a signing bonus of $88.743 million, the highest for a non-quarterback in league history. ...

Viking Masek Packaging Technologies announced this week that two company leaders have transitioned into passive investors.

Wells Fargo raised the price target for the Viking Holdings Ltd. (NYSE:VIK) stock to “an Overweight”. The rating was released on May 28, 2024, according to finviz. The research report from Stifel has ...

The company may look to license the experimental liver disease drug as it focuses on an obesity treatment that's shown early promise.

H.C. Wainwright analyst Joseph Pantginis has reiterated their bullish stance on VKTX stock, giving a Buy rating on June 2. Joseph Pantginis ...

Viking Therapeutics is pulling up some extra long boats full of reasons the metabolic dysfunction-associated steatohepatitis (MASH) drug VK2809 could be a winner, but executives were mum on exactly ...